Filing Flows › Chemours (CC) › Q4 2025
Chemours (CC) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 24, 2026
Chemours (CC) reported revenue of $1.3B for the fourth quarter 2025 (Q4 2025), -2% from a year earlier and -11% from the quarter before. Operating margin was -5.0%, net loss $47.0M (3.5% of revenue).
Chemours, Q4 2025: revenue $1.3B (-2% year over year), operating margin -5.0%, net loss $47.0M, operating cash flow $137M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3B | -11% | -2% |
| Operating profit | −$66.0M | -229% | — |
| Net earnings | −$47.0M | -178% | — |
| Operating cash flow | $137M | -6% | -0.7% |
| Free cash flow | $92.0M | -12% | +217% |
What changed
Revenue was $1.3B in Q4 2025, down 2% year over year and down 11% from the previous quarter. All Segments was the largest line at 99% of revenue.
Gross margin was 11.7%, down 7.8 points from a year earlier. Operating costs exceeded revenue by $0.07B, an operating margin of -5.0%. Operating expenses fell 16% while revenue fell 2%. The quarter ended with a net loss of $0.05B, after a profit of $0.05B the previous quarter.
Operating cash flow was $0.14B (down 1% year over year). Non-cash charges added back $0.08B of depreciation and amortization and $4.0M of share-based compensation. Working capital and other items added $0.10B. Capital expenditures of $0.04B left free cash flow of $0.09B.
Questions
What was Chemours' revenue in the fourth quarter 2025?
Chemours (CC) reported revenue of $1.3B for the fourth quarter 2025 (Q4 2025), -2% from a year earlier and -11% from the quarter before.
Was Chemours profitable in the fourth quarter 2025?
Operating loss was $66.0M (-5.0% of revenue) and net loss $47.0M.
Source: Chemours 10-K on SEC EDGAR.